Prophylactic antibiotics prevent bacterial biofilm graft infection.
Bacterial biofilm graft infection is due to prostheses colonization by Staphylococcus epidermidis, a pathogen frequently recovered from perigraft tissues of man during vascular procedures despite the use of asepsis and prophylactic antibiotics. The effect of preoperative intraperitoneal cefazolin, administered at a standard (15 or 30 mg/kg) and high (120 mg/kg) dose, on the prevention of bacterial biofilm infection was studied in a rat model. Seventy-four Dacron grafts, colonized in vitro with S. epidermidis to produce an adherent biofilm (3.19 +/- 0.71 x 10(7) colony-forming units/cm2 graft), were implanted in the dorsal subcutaneous tissue at 0.5, 2, and 4 hr after antibiotic administration. The study strain was a slime-producing clinical isolate with minimum inhibitory concentration (MIC) of 15-30 micrograms/ml to cefazolin. Subcutaneous tissue antibiotic levels were determined at each time interval. One week after implantation, the concentration of bacteria in the surface biofilm by quantitative agar culture was significantly decreased (P less than 0.05) only for grafts implanted when antibiotic tissue levels were greater than or equal to the MIC of the study strain. The result of no growth by biofilm broth culture was significantly achieved (P less than 0.01) only for grafts implanted 0.5 hr after high dose cefazolin, in which the tissue antibiotic level was above the MIC of the study strain. Antibiotics can markedly reduce the bacteria concentration of a prosthetic surface biofilm. The effectiveness of prophylactic antibiotics on the prevention of graft infection is dependent upon maintaining an adequate antibiotic level in the perigraft tissues for the duration of the procedure.
Bergamini
T M
TM
Department of Surgery, University of Louisville School of Medicine, Kentucky.
Peyton
J C
JC
Cheadle
W G
WG
D000818:Animals; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D002437:Cefazolin / Q000008:administration & dosage / Q000627:therapeutic use*; D003102:Colloids; D004305:Dose-Response Relationship, Drug; D005260:Female; D011091:Polyesters; D051381:Rats; D011919:Rats, Inbred Strains; D013530:Surgical Wound Infection / Q000517:prevention & control*
D003102:Colloids; D011091:Polyesters; D002437:Cefazolin